Medical Equipment

Versiti becomes 10th U.S. blood center to adopt FDA-cleared automation from Terumo Blood and Cell Technologies

Automated whole blood processing will expand platelet production capacity and help meet growing hospital demand LAKEWOOD, Colo. and MILWAUKEE, Oct. 19, 2026 /PRNewswire/ -- Versiti has become the 10th U.S. blood center to adopt the Reveos™ Automated Blood Processing System

2026-10-19 22:00 4683

Alloop Joins CaringKind's 38th Annual Alzheimer's Walk and Brain Health Day

NEW YORK, Oct. 19, 2026 /PRNewswire/ -- Alloop participated in CaringKind's 38th Annual Alzheimer's Walk and Brain Health Day in Central Park on October 17. The team joined the walk and hosted an on-site booth alongside people living with Alzheimer's disease and related demen...

2026-10-19 21:00 1441

Advanced Manufacturing in Focus: Smart Life and Robotics Take the Spotlight at 140th Canton Fair

GUANGZHOU, China, Oct. 18, 2026 /PRNewswire/ -- Phase 1 of the 140th Canton Fair, themed "Advanced Manufacturing," opened on October 15 and will run through October 19. As one of the event's most closely watched sections, the Consumer Electronics and Information Products zone once again serves as...

2026-10-18 19:00 3579

Lunit SCOPE Reveals HER2 Expression Differences Linked to Treatment Response Beyond Conventional Testing in Nature Medicine Study

AI-powered whole-slide analysis provides insights into treatment response beyond conventional HER2 classification SEOUL, South Korea, Oct. 14, 2026 /PRNewswire/ -- Lunit (KRX: 328130), a leading provider of AI for cancer diagnostics and precision oncology, today announced findings from a study p...

2026-10-14 21:00 2531

Neurophet Honored with Two Awards at the BioSpectrum Asia Excellence Awards 2026

* Receives Awards for MedTech Innovation and AI-Driven Clinical Development; Only Korean Company Recognized in Two Categories * Recognized for its capabilities in AI-driven clinical support and ICL services, with plans to expand partnerships with global CROs SEOUL, South Korea, Oct. 14, 2026 /...

2026-10-14 21:00 2189

MIRACELL to Host Stem Cell Science Day 2026 in Los Angeles, Featuring International Clinical Insights in Regenerative Medicine

- Leading South Korean and U.S. medical experts to share clinical insights into regenerative medicine - Austrian clinical study on 47 ACL rupture patients treated with SMART M-CELL published in peer-reviewed journal LOS ANGELES, Oct. 14, 2026 /PRNewswire/ -- Miracell U.S. Inc., the U.S. subsidi...

2026-10-14 19:00 1763

ELEHEAR Earns Two 2026 Hearing Technology Innovator Awards™ from Hearing Health & Technology Matters

Beyond 2 Pro and ElePro® Plus awarded industry recognition as ELEHEAR continues its mission to make personalized hearing care more accessible CHICAGO, Oct. 13, 2026 /PRNewswire/ -- ELEHEAR , a company specializing in AI-powered hearing solutions, has been named a two-time w...

2026-10-13 19:00 2312

Lunit and Discovery Life Sciences Collaborate to Expand AI-Powered Tissue Analysis for Biopharma Research

Collaboration expands access to Lunit's AI-powered pathology platform by combining it with Discovery Life Sciences' global biospecimen and specialty laboratory capabilities, enabling standardized tissue insights for biomarker research and drug development. SEOUL, South Korea, Oct. 12, 2026 /PRNe...

2026-10-12 21:00 2672

CLASSYS Appoints Former Bain & Company Partner Jung-hee Bae as Chief Commercial Officer to Accelerate Global Expansion and Growth

- Appoints Vice President Jung-hee Bae to lead the newly established Go-to-Market (GTM) Center, overseeing domestic and international sales and marketing - AI and data-driven marketing and operations expert to spearhead expansion across the Americas, China and Europe while reinforcing the company...

2026-10-12 14:49 4004

First Patient Dosed in Phase III Perioperative Study of Cadonilimab (PD-1/CTLA-4) in Colon Cancer

HONG KONG, Oct. 10, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the first patient has been dosed in a Phase III clinical study (COMPASSION-40/AK104-313) evaluating cadonilimab, its first-in-class PD-1/CTLA-4 bispecific antibody, as monotherapy in the neoa...

2026-10-10 12:41 3430

Wellysis Secures FDA 510(k) Clearance for AI-Powered ECG Analysis Software, S-Patch CardioAI

* Adds FDA-cleared AI analysis to Wellysis' S-Patch ECG monitoring solution, expanding its capabilities beyond ECG acquisition * Enables FDA-cleared AI analysis of S-Patch ECG data to be integrated into third-party ECG platforms and existing clinical workflows * Designed to streamline ECG re...

2026-10-08 22:00 4663

ZEISS acquires Ceres Holographics to accelerate holography industrialization

Combining decades-long holography expertise with complementary holographic innovations JENA, Germany, Oct. 8, 2026 /PRNewswire/ -- ZEISS has announced the acquisition of Ceres Holographics, a pioneering holographic technology company headquartered in Livingston, Scotland. Ceres Holographics beco...

2026-10-08 17:12 2105

Flat Medical Surpasses 30 U.S. Hospitals and Pain Centers Using the EpiFaith® Smart Syringe in Routine Clinical Practice

Adoption spans obstetric anesthesia and interventional pain management, as major integrated delivery networks begin groundwork for system-wide conversion AUSTIN, Texas, Oct. 7, 2026 /PRNewswire/ -- Flat Medical, a provider of precision needle access and guidance solutions for anesthesia, critical...

2026-10-07 20:08 3371

Cambridge Heartwear Awarded £184 Million NHS Tender for World's First Medical-Grade, Wirelessly Charged, Reusable ECG Wearable

CAMBRIDGE, England, Oct. 6, 2026 /PRNewswire/ -- Cambridge Heartwear® Limited ( www.camheartwear.com

2026-10-07 01:00 4701

XtalPi Debuts Kodexia™, the World's First Closed-Loop siRNA Platform Combining Generative AI with First-Principles Modeling

* This unified platform integrates sequence design, chemical modification, experimental validation, extrahepatic delivery design, and intellectual property strategy into an integrated computational–experimental workflow, pioneering in vivo efficacy prediction models to accelerate drug developme...

2026-10-06 22:42 5450

Datasea Reports Fiscal Year 2026 Results with Gross Profit Up 70.1% and Gross Margin Increased to 10.2% Despite Lower Revenue

Net Loss Narrowed 57.0% and Operating Cash Flow Turned Positive; Company Also Received an Additional 180-Day Nasdaq Compliance Period BEIJING, Oct. 5, 2026 /PRNewswire/ -- Datasea Intelligent Technology Ltd. (Nasdaq: DTSS) ("Datasea" or the "Company"), a technology company focused on acoustic in...

2026-10-05 22:13 9275

Symphony™ Randomized Controlled Trial Demonstrates Significantly Improved Healing of Diabetic Foot Ulcers

Published multicenter study found higher complete wound closure rates and faster healing with Symphony plus standard of care AUCKLAND, New Zealand, Oct. 5, 2026 /PRNewswire/ -- Aroa Biosurgery Limited (ASX: ARX), a soft tissue regeneration company, today announced positive results from a prospec...

2026-10-05 12:46 2791

Celaid Therapeutics Completes Second Close of Series B Financing Round

Shionogi & Co., Ltd. and Teikoku Ventures, Inc. Join the Round to Accelerate  U.S. Clinical Trial Preparations for CLD-001 TOKYO, Oct. 4, 2026 /PRNewswire/ -- Celaid Therapeutics Inc. (Head Office: Bunkyo-ku, Tokyo, Japan; President and CEO: Nobuyuki Arakawa; "Celaid") today announced the complet...

2026-10-05 09:30 2323

Advances in Digital Therapeutics and HoneyNaps AI Enhance Clinical Trial Efficiency

* Supporting pharmaceutical, medical device, wellness, and research organizations in obtaining standardized sleep data * Expanding the use of SOMNUM scoring technology to provide clinical analysis services tailored to each customer's research objectives * AI Technologies Supporting Global...

2026-10-01 19:00 3021

POMDOCTOR LIMITED Accelerates AI-Enabled Chronic Disease Management and RWD Commercialization

GUANGZHOU, China, Sept. 30, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a digital healthcare company focused on advancing AI-enabled healthcare solutions, today provided an update on the continued progress in the development and commercialization of its AI...

2026-09-30 20:00 1982
12345 ... 54

Week's Top Stories